BioNTech Investor Presentation Deck
Global Social Responsibility at Our Core
Democratize Access to Novel Medicines
11
COVID-19 vaccine pledge to COVAX and the world
2+ bn doses to low- and middle-income countries by end
of 2022
Development of new drugs for diseases with high unmet
medical need in low-income countries
Malaria
Tuberculosis
●
HIV
Start to establish mRNA production in Africa to ensure
local vaccine supply
Modular "BioN Tainer" mRNA production facilities as
technological solution to democratize access to novel
medicines
SBTI, Science Based Targets initiative (in line with Paris agreement)
1 base year: 2021; 2 encompasses adhering to ten principles on human rights, the environment and anti-corruption
TAIP P
Environmental & Climate Protection
Climate targets under SBTi
Scope 1 & 2:
absolute emission reduction of 42% by 20301
Responsible Governance
Practice good corporate governance and social
and societal responsibility
Signed UN Global Compact²
●
Attractive Employer
Recruitment of qualified employees
●
Specialists for scientific innovation and support
of global growth
BIONTECHView entire presentation